Patents by Inventor James S. Acierno

James S. Acierno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7041448
    Abstract: The present invention relates to identification of a gene that is inactivated in a mucolipidosis condition. In particular, the invention concerns mutations that disrupt a mucolipin, preferably MCOLN1, in mucolipidosis IV. Recombinant nucleic acids encoding mutant forms of MCOLN1, oligonucleotides specific for such mutations, and diagnostic and therapeutic applications related to these discoveries, are also contemplated.
    Type: Grant
    Filed: May 8, 2001
    Date of Patent: May 9, 2006
    Assignees: The ML4 Foundation, The General Hospital Corporation
    Inventors: Ehud Goldin, Susan A. Slaugenhaupt, Mei Sun, James S. Acierno, Jr.
  • Publication number: 20030064363
    Abstract: The present invention relates to identification of a gene that is inactivated in a mucolipidosis condition. In particular, the invention concerns mutations that disrupt a mucolipin, preferably MCOLN1, in mucolipidosis IV. Recombinant nucleic acids encoding mutant forms of MCOLN1, oligonucleotides specific for such mutations, and diagnostic and therapeutic applications related to these discoveries, are also contemplated.
    Type: Application
    Filed: May 8, 2001
    Publication date: April 3, 2003
    Applicant: The ML4 Foundation and President and Fellows of Havard College
    Inventors: Ehud Goldin, Susan A. Slaugenhaupt, Mei Sun, James S. Acierno